USPTO serial 79426343
QBE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 6, 2026
- Examiner
- O'BRIEN, JENNIFER LYNN
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with QBE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Bryan P. Clark
Bryan P. Clark The Webb Law Firm420 Fort Duquesne Boulevard, Suite 1200One Gateway CenterPittsburgh, PA 15222Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 007 | Bioreactors for industrial use for the manufacture of biocatalytic, biochemical, bioenergetic, biopharmaceutical, cell-based, fermented, and food-grade products; bioreactors for cell culturing for industry for the manufacture of biocatalytic, biochemical, bioenergetic, biopharmaceutical, cell-based, fermented, and food-grade products; cell culture apparatus being machines for industrial use for the manufacture of biocatalytic, biochemical, bioenergetic, biopharmaceutical, cell-based, fermented, and food-grade products; cell culture systems for industrial use comprised of machines for the manufacture of biocatalytic, biochemical, bioenergetic, biopharmaceutical, cell-based, fermented, and food-grade products; racks being machine parts for cell culture systems in the form of bioreactors for industrial use for the manufacture of biocatalytic, biochemical, bioenergetic, biopharmaceutical, cell-based, fermented, and food-grade products; racks being machine parts for bioreactors for industrial use for the manufacture of biocatalytic, biochemical, bioenergetic, biopharmaceutical, cell-based, fermented, and food-grade products; installations in the nature of machines for the production of pharmaceuticals; bioreactors for use in manufacturing biopharmaceuticals; structural parts for the aforesaid goods. | ACTIVE | — |
| 009 | Bioreactors for cell culturing for scientific research; cell culture apparatus for laboratory use, namely, disposable reaction vessels of plastic for cell cultures; cell culture apparatus for scientific use, namely bioreactors, cell culture dishes, cell culture plates, cell culture flasks, tissue culture flasks, sterile filters, and cell strainers; cell culture apparatus for laboratory use, namely bioreactors, cell culture dishes, cell culture plates, cell culture flasks, tissue culture flasks, sterile filters, and cell strainers; cell culture systems for scientific use comprised of cell culture apparatus for laboratory use, namely bioreactors, cell culture dishes, cell culture plates, cell culture flasks, tissue culture flasks, sterile filters, and cell strainers; racks being structural parts for cell culture systems, in particular in the form of bioreactors and fermenter apparatus, for scientific use; racks being structural parts for bioreactors for scientific use; racks being structural parts for fermenter apparatus for scientific use; structural parts for all of the aforesaid goods. | ACTIVE | — |
| 010 | Cell culture apparatus for medical use, namely bioreactors for medical use; bioreactors for cell culturing for medical purposes; cell culture apparatus for medical use namely, clinical cell culture incubators, tissue culture systems comprised of incubators for medical purposes, sample preparation device for medical diagnostic uses in the nature of blood and cell separators, bioreactors, aseptic isolators being sample preparation devices for medical diagnostic uses, sample preparation device for medical diagnostic uses in the nature of automated cell and media exchange systems, clinical-grade microscopes with image analysis for surgical operations, flow cytometers for medical diagnostic uses, automated cell counters with viability in the nature of flow cytometers and flow-based analyzers providing cell counting for medical, clinical, medical diagnostic, and therapeutic uses, sample preparation device for medical diagnostic uses in the nature of media and reagent preparation systems, and cell banking systems, for medical use comprised of sample preparation device for medical diagnostic uses; cell culture apparatus for medical use, namely, fermenter apparatus for medical purposes; cell culture systems for medical purposes comprised of clinical cell culture incubators, tissue culture systems comprised of incubators for medical purposes, sample preparation device for medical diagnostic uses in the nature of blood and cell separators, bioreactors, aseptic isolators being sample preparation devices for medical diagnostic uses, sample preparation device for medical diagnostic uses in the nature of automated cell and media exchange systems, clinical-grade microscopes with image analysis for surgical operations, flow cytometers for medical diagnostic uses, automated cell counters with viability in the nature of flow cytometers and flow-based analyzers providing cell counting for medical, clinical, medical diagnostic, and therapeutic uses, sample preparation device for medical diagnostic uses in the nature of media and reagent preparation systems, and cell banking systems comprised of sample preparation device for medical diagnostic uses; cell culture apparatus for medical use, namely, racks for cell culture systems, in particular in the form of bioreactors and fermenter apparatus, for medical purposes; cell culture apparatus for medical use, namely, racks for bioreactors for medical purposes; cell culture apparatus for medical use, namely, racks for fermenter apparatus for medical purposes; structural parts for the aforesaid goods. | ACTIVE | — |
| 011 | Fermentation apparatus for industrial purposes; Fermentation apparatus for the manufacture of biopharmaceuticals; racks being structural parts for fermentation apparatus for industrial purposes; structural parts for the aforesaid goods. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Glatt GmbH
- Other trademarks owned by Glatt GmbH
- Other trademarks owned by Glatt GmbH
- Other trademarks in Class 007
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 011
- Similar marks named QBE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 6, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 6, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 18, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 18, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 12, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 23, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 9, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 9, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 9, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 9, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 2, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 2, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 2, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 21, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 21, 2026 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| May 21, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 21, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 21, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 21, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 19, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 19, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 19, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 5, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 19, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 19, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 30, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 29, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 28, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 20, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 20, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 19, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |